Feedback to MHRA / British Pharmacopoeia: Guidance on the application of vector copy number for the cell and gene therapy community​

High Level Analytics members participated in a series of meetings to review British Pharmacopoeia: Guidance on the application of vector copy number for the cell and gene therapy community​ which was published for public consultation July 2021.

A summary document detailing consolidated feedback and suggested recommendations that represented the views of member companies was submitted to the MHRA in October 2021

This document is reserved for the use of BioPhorum members only.

I don't have access to this document

Make a selection below and submit your request. We will get back to you ASAP.

My company would like to become a member

If you're not sure if your company is a member of this Phorum, or if you would like to enquire on behalf of your company about becoming a member, please see our membership page.

Preview